Johnson & Johnson , through its affiliate JHC Nederland B.V. , has also purchased 14.6 million newly issued ordinary shares of Crucell , representing approximately 18 % of Crucell 's outstanding ordinary shares , for an aggregate purchase price of euro 301.8 million . In addition , the companies have agreed to development milestones and royalty payments based on the successful development and commercialization of products in connection with the collaboration .